Tixagevimab/Cilgavimab (EVUSHELDTM): Evidence-Based Health Information Related to COVID-19

Treatment of COVID-19 with Evusheld: A Canadian Perspective on the TACKLE trialПодробнее

Real-world study of tixagevimab/cilgavimab in pre-exposure prophylaxis for alloSCT recipientsПодробнее

Oral Therapies for SARS-CoV-2: Evidence-Based Health Information Related to COVID-19Подробнее

Evusheld: A Drug to Prevent COVID19 ... and REPLACE Vaccines?Подробнее

COVID-19 prevention drug Evusheld reduces risk: ReportПодробнее

'Game Changer': TGH offers new Evusheld COVID-19 antibody treatmentПодробнее

In-Depth: Is AstraZeneca's Evusheld a turning point against COVID?Подробнее

COVID-19 Vaccine Updates: New Strategies to Address Vaccine HesitancyПодробнее

Updates to Vermont’s COVID-19 Therapeutics ProgramПодробнее

San Diego immunocompromised patient desperately searching for life changing therapeuticПодробнее

Rio Grande Valley Patients Receive New Treatment to Prevent COVID-19Подробнее

Top former US public health official grilled over COVID-19 pandemic response | 9 News AustraliaПодробнее

COVID-19 Treatment and ProphylaxisПодробнее

Dr. Anthony Fauci Testifies on Origins of COVID-19Подробнее

Meet the InteliSwab™ COVID-19 Rapid Test V1Подробнее

Watch: Fauci testifies on COVID originsПодробнее

Arthritis drug may cut Covid hospital deaths by half - BBC NewsПодробнее